Hyperlipoproteinemia Type II

A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Also Known As:

Familial Hypercholesterolemia; Hypercholesterolemia, Familial; Apolipoprotein B-100, Familial Ligand-Defective; Familial Combined Hyperlipoproteinemia; Hyper-Low Density Lipoproteinemia; Hyper-beta-Lipoproteinemia; Hypercholesterolemia, Autosomal Dominant; Hypercholesterolemia, Autosomal Dominant, Type B; Hyperlipoproteinemia Type 2; Hyperlipoproteinemia Type IIa; Hyperlipoproteinemia Type IIb; LDL Receptor Disorder; 2, Hyperlipoproteinemia Type; 2s, Hyperlipoproteinemia Type; Apolipoprotein B 100, Familial Ligand Defective; Autosomal Dominant Hypercholesterolemia; Autosomal Dominant Hypercholesterolemias; Combined Hyperlipoproteinemia, Familial; Combined Hyperlipoproteinemias, Familial; Density Lipoproteinemia, Hyper-Low; Density Lipoproteinemias, Hyper-Low; Disorder, LDL Receptor; Disorders, LDL Receptor; Dominant Hypercholesterolemia, Autosomal; Dominant Hypercholesterolemias, Autosomal; Essential Hypercholesterolemia; Essential Hypercholesterolemias; Familial Combined Hyperlipoproteinemias; Familial Hypercholesterolemias; Hyper Low Density Lipoproteinemia; Hyper beta Lipoproteinemia; Hyper-Low Density Lipoproteinemias; Hyper-beta-Lipoproteinemias; Hyperbetalipoproteinemias; Hypercholesterolemias, Autosomal Dominant; Hypercholesterolemias, Essential; Hypercholesterolemias, Familial; Hyperlipoproteinemia Type 2s; Hyperlipoproteinemia Type IIas; Hyperlipoproteinemia Type IIbs; Hyperlipoproteinemia Type IIs; Hyperlipoproteinemia, Familial Combined; Hyperlipoproteinemias, Familial Combined; LDL Receptor Disorders; Lipoproteinemia, Hyper-Low Density; Lipoproteinemias, Hyper-Low Density; Receptor Disorder, LDL; Receptor Disorders, LDL; Type 2, Hyperlipoproteinemia; Type 2s, Hyperlipoproteinemia; Hyperbetalipoproteinemia; Hypercholesterolemia, Essential

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 449
- Inborn Genetic Diseases: 568
  - Inborn Errors Metabolism: 437
    - Inborn Errors Lipid Metabolism
      - Hyperlipoproteinemia Type II: 2063
Nutritional and Metabolic Diseases
- Metabolic Diseases: 1419
  - Inborn Errors Metabolism: 437
    - Inborn Errors Lipid Metabolism
      - Hyperlipoproteinemia Type II: 2063
  - Lipid Metabolism Disorders: 91
    - Dyslipidemias: 4386
      - Hyperlipidemias: 6848
        Hyperlipoproteinemias: 1433
        Hyperlipoproteinemia Type II: 2063

M A Lasuncion Selected Research

M A Lasuncion Research Topics

Disease

Drug/Important Bio-Agent (IBA)